Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082379 · ClinicalTrials.gov registry record · NA
In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route
A NA study, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02082379 is a NA study that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 21 participants.
The verdict
NCT02082379, a NA study, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
We hypothesize that infant and children will show different levels of acceptance of different interfaces while they receive inhaled therapy. We also hypothesize that children will exhibit different amounts of time with the aerosol well aligned with the nostrils during transnasal aerosol delivery.
Interventions
- BEHAVIORAL inhaled normal saline using different interfaces.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02082379
The ClinicalTrials.gov registry entry for NCT02082379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which inhaled normal saline using different interfaces. is the first listed.
NCT02082379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02082379 about?
NCT02082379 is a clinical study titled "In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route". We hypothesize that infant and children will show different levels of acceptance of different interfaces while they receive inhaled therapy. We also hypothesize that children will exhibit different amounts of time with the aerosol well aligned with the nostrils during transnasal aerosol delivery.
What is the current status of trial NCT02082379?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-01. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02082379?
The interventions under investigation include: inhaled normal saline using different interfaces. (BEHAVIORAL).
Who is sponsoring clinical trial NCT02082379?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.